BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31317672)

  • 21. Improvement in Lung Cancer Survival: 6-Year Trends of Overall Survival at Hungarian Patients Diagnosed in 2011-2016.
    Bogos K; Kiss Z; Tamási L; Ostoros G; Müller V; Urbán L; Bittner N; Sárosi V; Vastag A; Polányi Z; Nagy-Erdei Z; Daniel A; Vokó Z; Nagy B; Horváth K; Rokszin G; Abonyi-Tóth Z; Barcza Z; Gálffy G; Moldvay J
    Pathol Oncol Res; 2021; 27():603937. PubMed ID: 34257563
    [No Abstract]   [Full Text] [Related]  

  • 22. Early mortality in lung cancer: French prospective multicentre observational study.
    Grivaux M; Debieuvre D; Herman D; Lemonnier C; Marcos JM; Crequit J; Vuillermoz-Blas S; Barre P; Saillour M; Martin F
    BMC Pulm Med; 2016 Apr; 16():45. PubMed ID: 27039176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors in lung cancer in a defined geographical area over two decades with a special emphasis on gender.
    Svensson G; Ewers SB; Ohlsson O; Olsson H
    Clin Respir J; 2013 Jan; 7(1):91-100. PubMed ID: 22380488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical features and prognosis of multiple primary tumors of lung combined with other organs--report of 281 cases].
    Yi SZ; Zhang DC; Wang YG; Sun KL
    Ai Zheng; 2006 Jun; 25(6):731-5. PubMed ID: 16764770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment patterns and overall survival among patients with unresectable, stage III non-small-cell lung cancer.
    Bobbili P; Ryan K; Duh MS; Dua A; Fernandes AW; Pavilack M; Gomez JE
    Future Oncol; 2019 Oct; 15(29):3381-3393. PubMed ID: 31544510
    [No Abstract]   [Full Text] [Related]  

  • 26. Genetic Investigation of Polymorphic OGG1 and MUTYH Genes Towards Increased Susceptibility in Lung Adenocarcinoma and its Impact on Overall Survival of Lung Cancer Patients Treated with Platinum Based Chemotherapy.
    Singh A; Singh N; Behera D; Sharma S
    Pathol Oncol Res; 2019 Oct; 25(4):1327-1340. PubMed ID: 29209987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of histology on patterns of failure and clinical outcomes in patients treated with definitive chemoradiotherapy for locally advanced non-small cell lung cancer.
    Ito H; Matsuo Y; Ohtsu S; Nishimura T; Terada Y; Sakamoto T; Mizowaki T
    Int J Clin Oncol; 2020 Feb; 25(2):274-281. PubMed ID: 31667664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hospitalization and definitive radiotherapy in lung cancer: incidence, risk factors and survival impact.
    Hazell SZ; Mai N; Fu W; Hu C; Friedes C; Negron A; Voong KR; Feliciano JL; Han P; Myers S; McNutt TR; Hales RK
    BMC Cancer; 2020 Apr; 20(1):334. PubMed ID: 32306924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of patients with lung cancer in the city of Manaus, Brazil.
    Westphal FL; Lima LC; Andrade EO; Lima Netto JC; Silva AS; Carvalho BC
    J Bras Pneumol; 2009 Feb; 35(2):157-63. PubMed ID: 19287919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival Comparison in Patients with Stage IV Lung Cancer in Academic versus Community Centers in the United States.
    Ramalingam S; Dinan MA; Crawford J
    J Thorac Oncol; 2018 Dec; 13(12):1842-1850. PubMed ID: 30312680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening Patterns and Mortality Differences in Patients With Lung Cancer at an Urban Underserved Community.
    Su CT; Bhargava A; Shah CD; Halmos B; Gucalp RA; Packer SH; Ohri N; Haramati LB; Perez-Soler R; Cheng H
    Clin Lung Cancer; 2018 Sep; 19(5):e767-e773. PubMed ID: 29937386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Second malignancy in non-small cell lung cancer (NSCLC): prevalence and overall survival (OS) in routine clinical practice.
    Faehling M; Schwenk B; Kramberg S; Fallscheer S; Leschke M; Sträter J; Eckert R
    J Cancer Res Clin Oncol; 2018 Oct; 144(10):2059-2066. PubMed ID: 30062488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lung cancer outcome in the setting of chronic kidney disease: Does the glomerular filtration estimation formula matter?
    Lu MS; Lu HI; Chen TP; Chen MF; Lin CC; Tseng YH; Tsai YH
    Thorac Cancer; 2019 Feb; 10(2):268-276. PubMed ID: 30586226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma.
    Qian F; Yang W; Wang R; Xu J; Wang S; Zhang Y; Jin B; Yu K; Han B
    J Thorac Cardiovasc Surg; 2018 Mar; 155(3):1227-1235.e2. PubMed ID: 29223834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer.
    Fukui T; Itabashi M; Ishihara M; Hiyoshi Y; Kasajima M; Igawa S; Sasaki J; Masuda N
    BMC Cancer; 2016 Mar; 16():197. PubMed ID: 26955807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases.
    Radzikowska E; Głaz P; Roszkowski K
    Ann Oncol; 2002 Jul; 13(7):1087-93. PubMed ID: 12176788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
    Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
    Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delay between the initial symptoms, the diagnosis and the onset of specific treatment in elderly patients with lung cancer.
    Giroux Leprieur E; Labrune S; Giraud V; Gendry T; Cobarzan D; Chinet T
    Clin Lung Cancer; 2012 Sep; 13(5):363-8. PubMed ID: 22264658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors and outcome of surgically treated patients with brain metastases of non-small cell lung cancer.
    She C; Wang R; Lu C; Sun Z; Li P; Yin Q; Liu Q; Wang P; Li W
    Thorac Cancer; 2019 Feb; 10(2):137-142. PubMed ID: 30485664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cluster Analysis Evaluating PM2.5, Occupation Risk and Mode of Transportation as Surrogates for Air-pollution and the Impact on Lung Cancer Diagnosis and 1-Year Mortality.
    Abdul Wahab S; Hassan A; Latif MT; Vadiveel Y; Jeyabalan T; Soo CI; Abdul Hamid F; Yu-Lin AB; Hassan T
    Asian Pac J Cancer Prev; 2019 Jul; 20(7):1959-1965. PubMed ID: 31350951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.